tirzepatide cardiovascular outcomes study with Compared with Dulaglutide in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular tirzepatide cardiovascular outcomes trial results

Some patients on Tirzepatide have reported losing up to 20% of their body weight

Most commentary addresses administrative flow and pharmacy coordination rather than clinical results or safety outcomes

Intervals (short sprints, circuits, rower blasts) 12/week help maintain insulin sensitivity

Diverticulitis is a digestive condition wherein small pouches (diverticula) in the wall of the colon (large intestine) become swollen or infected

Its use is considered illegal in many countries, and it is often sold on the gray market, where product quality and purity are not guaranteed, posing additional health risks

In meta-analyses of observational studies, GLP-1 RAs also reduced the risk of HF hospitalization individuals with T2DM without serious cardiovascular events (Class IV